ライフサイエンスコーパス: test battery

1 d daily on a computerized neuropsychological test battery.

2 groups on the audiological component of the test battery.

3 f Battery, a computer-administered cognitive test battery.

4 ion were assessed via computerized cognitive test battery.

5 rtainment strategy, ethnicity, and cognitive test battery.

6 y (PwE) together with an extensive cognitive test battery.

7 imaging, and underwent a neuropsychological test battery.

8 l study on the primary endpoint, a cognitive-test battery.

9 e PCR) were assessed with a neuropsychologic test battery.

10 e PCR) were assessed with a neuropsychologic test battery.

11 l deficits were evaluated by a comprehensive test battery.

12 the existing pre-clinical rodent touchscreen test battery.

13 n was measured using the Cognitron cognitive test battery.

14 d following the ALPHA health-related fitness test battery.

15 scores, all of which were derived from a 12-test battery.

16 We implemented a detailed 2-h cognitive test battery.

17 stimuli during performance of the Emotional Test Battery.

18 administered computerized neuropsychological test battery.

19 o Establish a Registry for Alzheimer Disease test battery.

20 assessed with a detailed neuropsychological test battery.

21 inst a gold standard neuropsychological (NP) test battery.

22 negative facial expressions in an emotional test battery.

23 mentia was evaluated with neuropsychological test battery.

24 utive function were derived from a cognitive test battery.

25 ividuals by using a comprehensive laboratory test battery.

26 s assessed by using a computerized cognitive test battery.

27 ning tasks and a detailed neuropsychological test battery.

28 fitness was assessed using the ALPHA-fitness test battery.

29 ng blood draw and a brief neuropsychological test battery.

30 Patients also completed a neuropsychological test battery.

31 CN mutant mice to a comprehensive behavioral test battery.

32 rld Health Organization Neurobehavioral Core Test Battery.

33 ia completed an extensive neuropsychological test battery.

34 pairs, on a comprehensive neuropsychological test battery.

35 measures of AN function in standard clinical test batteries.

36 dexterity, ball skills, agility and balance) test batteries.

37 = 0.033) as measured using age-standardised test batteries.

38 (n = 177), they completed cognitive ability test batteries.

39 ividuals' aggregate performance in cognitive test batteries [1-9].

40 A cognitive test battery (10 measures assessing 7 cognitive domains)

41 re, we utilized a modified Primate Cognitive Test Battery [13] in conjunction with quantitative genet

42 ition based on a modified Neuropsychological Test Battery (14 tests).

43 lation to chronic impairment on a behavioral test battery; 2) Amenability to change using a skilled m

44 urthermore, utilizing large-scale behavioral test battery, a multivariate cross-validated prediction

45 From the entire neuropsychological test battery, a stepwise selection procedure retained 2

46 when cognitive function was assessed using a test battery adapted for participants with hearing loss.

47 were (1) a cognitive factor score based on a test battery adapted from several standard tests, 2) fin

48 nsgenic (NT) mice in an extensive behavioral test battery administered between 5 and 8.5 months of ag

49 We repeated the standardized cognitive test battery after a mean of 4.6 years (standard deviati

50 s in the performance of animals on cognitive test batteries analogous to those of humans?

51 ted using a comprehensive neuropsychological test battery and a derived measure from the Heinrichs-Ca

52 e function was assessed with a comprehensive test battery and a global composite score was derived.

53 th groups were administered a neurocognitive test battery and a standardized RCC measure (Capacity to

54 dual was assessed with a screening cognitive test battery and an extended cognitive test battery at b

55 replacement, completed a neuropsychological test battery and brain MRI scan before surgery and on da

56 cterise cognitive domains underlying a large test battery and for the first time, evaluate their abil

57 h participant completed a neuropsychological test battery and had clinical cognitive status (dementia

58 completed a comprehensive neuropsychological test battery and informant interview, none of whom were

59 Using a comprehensive neuropsychological test battery and large sample, the national prevalence o

60 ing Test, Word Learning Lists from the CERAD test battery and Mini Mental State Examination; MMSE).

61 years) were assessed using a neurocognitive test battery and parent-report behavioral questionnaires

62 he authors administered a neuropsychological test battery and temperament questionnaires to samples o

63 erity was measured with a neuropsychological test battery and the Catherine Bergego Scale, at admissi

64 ects completed a detailed neuropsychological test battery and were classified as impaired or unimpair

65 ophrenia completed a comprehensive cognitive test battery and were rated on symptom measures at index

66 and PHES were compared using a computerized test battery and West Haven criteria as reference.

67 findings to performance on a neurocognitive test battery, and found that N-acetylaspartylglutamate (

68 inistered a comprehensive neuropsychological test battery, and neurological signs were assessed with

69 Many neuropsychological test batteries are comprehensive and require specialized

70 Current test batteries are either limited in scope or are of an

71 Validated test batteries are now available that may prove to be of

72 A comprehensive binocular vision test battery as a gold standard were administered on rec

73 A comprehensive neuropsychological test battery assessed executive functions and processing

74 mal control subjects on a neuropsychological test battery assessing a range of cognitive domains.

75 cedures comprise part of a wider touchscreen test battery assessing cognition in rodents with high po

76 urity and a comprehensive neuropsychological test battery assessing executive function, processing sp

77 A cognitive test battery assessing memory, attention, language, visu

78 Finally, we utilized a behavior test battery at a single dosing regimen that produces bl

79 administered a comprehensive neurocognitive test battery at baseline and 2 y.

80 completed a comprehensive neuropsychological test battery at baseline and again at an 8-week follow-u

81 itive test battery and an extended cognitive test battery at baseline and biennially during the plann

82 , individuals completed a neuropsychological testing battery at each clinical visit that included the

83 ng a validated, psychological computer-based test battery before and after each diet.

84 rief and self-administered digital cognitive test battery (BioCog).

85 IV RNA <250 copies/mL) completed a cognitive test battery, blood draw, and whole-blood immunophenotyp

86 a brief, self-administered digital cognitive test battery can detect cognitive impairment and, when c

87 xpression analysis, computer-based cognitive testing battery (CANTAB) and serum NMR metabolomics were

88 been adapted from a human neuropsychological testing battery (CANTAB, Cambridge Cognition, Ltd) for u

89 headache questionnaires, neuropsychological test battery, combat exposure and alcohol use surveys, a

90 types were assessed using nine comprehensive test batteries consisting of twenty-one cognitive perfor

91 The study patients were given a test battery consisting of a questionnaire specific for

92 ent Metrics (ANAM), a computerized cognitive testing battery consisting of cognitive subtests, a slee

93 us, processing these chemicals using current test batteries could require millions of dollars and dec

94 ht result from procedural inconsistencies in test battery design, but also from differences in how an

95 linical Global Impression (CGI) scale, and a test battery designed to measure cognitive function in p

96 velopment Study completed the novel "Bricks" test battery, designed to tap these abilities in isolati

97 ndicators of efficacy, such as the Emotional Test Battery, EEG markers, and fMRI correlates of anhedo

98 and overall toxicological activity across a test battery, enabling direct comparison of BPA with its

99 subset of mice was assessed in a behavioral test battery following LPS-induced sickness recovery.

100 n important complement for existing in vitro test batteries for water quality testing and has potenti

101 were administered a full neuropsychological test battery for cognitive performance.

102 can thus be used as part of a comprehensive test battery for learning and memory in this species.

103 ns underwent an extensive neuropsychological test battery, from which an mean z score of global cogni

104 d elsewhere) was assessed using an extensive test battery; global cognitive functioning as assessed b

105 r using a standardized and adapted cognitive test battery in CI recipients.

106 on and followed by a mask, and the Emotional Test Battery in which reaction times and performance acc

107 A neurocognitive test battery included domain-specific assessments of lea

108 A cognitive test battery included the Kendrick Object Learning Test,

109 The cognitive testing battery included measures of executive function,

110 The test battery including Barthel index of Activities of Da

111 cognitive function, as well as a behavioral test battery including the Problem Behavior Assessment f

112 A test battery, including the Stop Signal, Digit Span, and

113 toxicity findings using the current in vitro testing battery is a major challenge to industry and reg

114 Project, who completed a neuropsychological test battery measuring 4 EFs (switching, inhibitory cont

115 search assistants using a neuropsychological test battery measuring simple and complex attention, pro

116 ing chimpanzee- and human-specific cognitive test batteries, measuring aspects of cognition related t

117 A cognitive test battery modeled after the one used in the Women's H

118 hs, and 12 months using a neuropsychological test battery (NTB) of memory, executive function, and at

119 endpoint was change in a neuropsychological test battery (NTB) score.

120 cally assessed using the computer-aided TAP (Test Battery of Attentional Performance).

121 administered an extensive neuropsychological test battery organized into the following 5 functions: a

122 mental test-batteries, the Primate Cognition Test Battery (PCTB), to raven features enabling also a d

123 e in a composite modified Neuropsychological Test Battery; preplanned secondary outcomes were change

124 ociated with self-report of tinnitus using a test battery probing the different stages of the auditor

125 During the Emotional Test Battery, reaction times decreased to identification

126 nd patients completed the neuropsychological test battery recommended by the ACR, the Center for Epid

127 he Cambridge Gambling Task and the Emotional Testing Battery, respectively.

128 verbal and math abilities, with a variety of test batteries scheduled at different time points in the

129 measured by a decrease in neuropsychological test battery scores (Mini-Mental State Examination, Lett

130 verage group results of the neuropsychologic test battery showed no impairment, but deficits (z score

131 verage group results of the neuropsychologic test battery showed no impairment, but deficits (z score

132 ning was assessed using a neuropsychological test battery, subjective cognitive complaints using a st

133 In the cognitive test battery, subjects in the xanomeline group showed im

134 r emphasize the quest to develop comparative test batteries that tap into true species rather than hu

135 phisticated and extensive neurodevelopmental test battery that addressed 17 specific outcomes in mult

136 bjects on a comprehensive neuropsychological test battery that assessed cognitive function.

137 and female wild-type and GluR-A-/- mice on a test battery that assessed sensorimotor, affective, and

138 Female: 76%), were studied with an auditory test battery that included audiometry and ABR measures.

139 All subjects underwent a neuropsychological test battery that included tasks found to be sensitive t

140 section for tumour or epilepsy), utilizing a test battery that is sensitive to semantic impairment in

141 ugh the use of a computerized neurocognitive test battery that provided measures of accuracy and spee

142 When tested on multiple test batteries, the overall performance ranks of individ

143 d one of the most comprehensive experimental test-batteries, the Primate Cognition Test Battery (PCTB

144 cy" factor derived from a neuropsychological test battery; this relationship was also age invariant.

145 may complement 3Rs (reduce, refine, replace) test batteries through its ADH metabolic capacity.

146 and 28, we administered a neuropsychological test battery to assess general intellectual function, ab

147 luences psychosocial outcomes, (3) the ideal test battery to assess the psychosocial benefits of grou

148 The authors used a neuropsychological test battery to characterize the neuropsychiatric profil

149 egistry for Alzheimer's Disease (CERAD)-Plus test battery to establish latent factors representing co

150 Hg <4 microg/l), applying a neurobehavioral test battery to evaluate CNS functions in relation to bo

151 We used a comprehensive neuropsychological test battery to evaluate cognitive function longitudinal

152 EFs were assessed with a neuropsychological test battery to produce an age-adjusted EF summary score

153 o 60 years) were administered a standardized testing battery to assess cardiovascular reactivity to m

154 cross-sectionally and longitudinally using a test battery, to specify age periods when changes most p

155 m the Cambridge Automated Neuropsychological Test Battery (Tower of London, spatial working memory, i

156 A test battery using sensory psychophysics, psychometric t

157 ratively before tumor resection a functional test battery [video head-impulse test (vHIT) of all semi

158 A test battery was administered that comprised three sets

159 A neuropsychological test battery was administered to patients with a diagnos

160 An extensive neuropsychological test battery was administered, and multivariate analysis

161 and finds that others for which the original test battery was inconclusive are not actually significa

162 were ruled out and the microbiological blood test battery was only positive for immunoglobulin M (IgM

163 A behavioral test battery was used to assess anxiety-like, depressive

164 A neuropsychological test battery was used to assess cognition.

165 A neurocognitive test battery was used to assess speed of processing, att

166 Using a standardized neuropsychological test battery, we assessed processing speed, executive fu

167 itive screening tools and neuropsychological test batteries were 44%, 16% and 21-34% respectively (ve

168 participants repeated the original KEEPS-Cog test battery which was analyzed using 4 cognitive factor

169 ough a comparative, multi-trait multi-method test battery with preschoolers (N = 185) and chimpanzees